We provide you with 20 years of free, institutional-grade data for NBRV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NBRV. Explore the full financial landscape of NBRV stock.
| Reported Date | CIK | Ticker | Type |
|---|
Nabriva Therapeutics plc(NASDAQ:NBRV) 
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneu...
The information provided in this report about NBRV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.